Newsletter Header.png

Did someone forward this to you? Subscribe to get updates and funding announcements directly in your inbox.



Applications are now open for 2024 Drug Delivery and Drug Discovery Targets and Pathways fellowships and grants. Help spread the word about these funding opportunities! Letters of intent due May 15.

Before You Apply: Learn the Do’s and Don’ts of Writing a Standout LOI and Application

Watch our recent webinar for advice from former PhRMA Foundation Scientific Advisory Committee member Dr. Stephanie Watts, a professor of pharmacology and toxicology at Michigan State University. Read the summary blog and view the "Do's and Don'ts" infographic.

Upcoming Deadline: Value Assessment Award

This new multiyear funding opportunity seeks research proposals for empirical studies that apply a published value assessment framework to determine the value of health care interventions. Letters of intent due April 14.


2022 Annual Report

Read the Annual Report for an overview of the PhRMA Foundation's activities and to learn about our 2022 awardees, including summaries of their research projects.

In 2022, the Foundation awarded 37 researchers a total of nearly $2.7 million.

View our "Year in Review" infographic


Driving Progress in U.S. Value Assessment

In the wake of recent health care policy changes, value assessment research has taken on even greater importance. This PhRMA Foundation white paper:

  • Reviews the U.S. value assessment landscape
  • Identifies key challenges
  • Highlights how Foundation-funded researchers are working toward solutions

Read the white paper.

Watch the related webinar:

Foundation Interview with The Evidence Base

Head of Communications Emily Ortman talked about the white paper and the PhRMA Foundation's value assessment work in a recent interview.


Exploring Career Paths: Biogen’s PhD Fellowships

What is it like transitioning from academia to industry? Watch this PhRMA Foundation webinar to find out. Biogen’s two-year PhD fellowship provides recent doctoral graduates an opportunity to learn the ins and outs of medical affairs and the pharmaceutical industry. In this webinar, the program director gives an overview of the program, and current and former fellows discuss their experiences. Watch the webinar. 

This webinar is the part of our series on exploring career paths and honing professional skills. See more.


Congrats to these Foundation-funded researchers on their recent work!

Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment, Journal of Managed Care & Specialty Pharmacy

Diana Brixner, RPh, PhD, University of Utah

Rapid Single-Shot Synthesis of the 214 Amino Acid-Long N-Terminal Domain of Pyocin S2, ACS Chemical Biology

Joseph Brown, PhD, Massachusetts Institute of Technology

Chemical Flavorants in Vaping Products Alter Neurobiology in a Sex-Dependent Manner to Promote Vaping-Related Behaviors, Journal of Neuroscience

Skylar Cooper, PhD, Marshall University

Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs, American Journal of Preventive Medicine

Vakaramoko Diaby, PhD, University of Florida

Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer, JNCI: Journal of the National Cancer Institute

Xin Hu, Emory University

Suicide Risk Among Individuals Diagnosed With Cancer in the US, 2000-2016, JAMA Network Open

Xin Hu, Emory University

Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates, Sciences Advances

Madeleine Landry, Oregon State University

Nanoscale Hafnium Metal-Organic Frameworks Enhance Radiotherapeutic Effects by Upregulation of Type I Interferon and TLR7 Expression, Advanced Healthcare Materials

Madeleine Landry, Oregon State University

Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy, International Journal of Pharmaceutics

Jianqin Lu, PhD, University of Arizona

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint, Proceedings of the National Academy of Sciences

Srividya Swaminathan, PhD, City of Hope

Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms, Communications Biology

Srividya Swaminathan, PhD, City of Hope

Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review, MDM Policy & Practice

Wendy J. Ungar, PhD, Hospital for Sick Children

A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease, Journal of the Canadian Association of Gastroenterology

Wendy J. Ungar, PhD, Hospital for Sick Children

Tradeoffs in Triage of Motor Vehicle Trauma by Rural 911 Emergency Medical Services Practitioners, Medical Decision Making

Eline van den Broek-Altenburg, PhD, University of Vermont

PhRMA_Foundation logo.gif
LinkedIn  Twitter